OAK INVESTMENT PARTNERS XII L P 4
4 · 1Life Healthcare Inc · Filed Feb 4, 2020
Insider Transaction Report
Form 4
OAK INVESTMENT PARTNERS XII L P
10% Owner
Transactions
- Conversion
Series E Preferred Stock
2020-02-04−2,308,074→ 0 total(indirect: See Footnote)→ Common Stock (2,308,074 underlying) - Conversion
Series D Preferred Stock
2020-02-04−9,519,276→ 0 total(indirect: See Footnote)→ Common Stock (9,519,276 underlying) - Conversion
Warrant (Right to Buy)
2020-02-04−10,837→ 0 total(indirect: See Footnote)Exercise: $6.59Exp: 2020-10-05→ Series G Preferred Stock (10,837 underlying) - Conversion
Warrant (Right to Buy)
2020-02-04+10,837→ 10,837 total(indirect: See Footnote)Exercise: $6.59Exp: 2020-10-05→ Common Stock (10,837 underlying) - Conversion
Common Stock
2020-02-04+2,308,074→ 12,011,380 total(indirect: See Footnote) - Conversion
Common Stock
2020-02-04+9,519,276→ 9,703,306 total(indirect: See Footnote)
Footnotes (3)
- [F1]Each share of Issuer's Preferred Stock automatically converted into an equal number of shares of Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.
- [F2]Securities held by Oak Investment Partners XII, L.P., or Oak XII. Oak XII is managed by its general partner, Oak Associates XII, LLC, or Oak Associates XII. Ann H. Lamont, Bandel L. Carano, Edward F. Glassmeyer and Frederic W. Harman, collectively serve as Executive Managing Members of Oak Associates XII, or the Executive Managing Members. The Executive Managing Members have shared voting and investment control over all of the securities held by Oak XII. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership (as defined in Rule 16a-1(a)(2)) of the securities held by Oak XII, except to the extent of such person or entity's pecuniary interest in such securities.
- [F3]Shares subject to the warrant are immediately exercisable.